Sara Saberi MD
Adult Congenital Heart Disease, Cardiac Electrophysiology, Echocardiography, Cardiovascular Disease Genetics
Physician
Join to View Full Profile
1500 E Medical Center DrAnn Arbor, MI 48109
Phone+1 734-936-4000
Dr. Saberi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MichiganFellowship, Cardiovascular Disease, 2007 - 2010- University of MichiganResidency, Internal Medicine, 2003 - 2006
Wayne State University School of MedicineClass of 2003
Certifications & Licensure
MI State Medical License 2003 - 2025
American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Study of Exercise Training in Hypertrophic Cardiomyopathy Start of enrollment: 2010 Apr 01
Publications & Presentations
PubMed
- Limited Concordance of Left Ventricular Ejection Fraction and Chamber Dimensions With Automated Assessments in Hypertrophic Cardiomyopathy: A Substudy From VALOR-HCM.Gary Parizher, Alice Haouzi, Wael A Jaber, Anjali Owens, Kathy Wolski
Journal of the American Society of Echocardiography. 2025-04-01 - Long-term Effects of Mavacamten on Patients Based on Hypertrophic Cardiomyopathy Pathogenic Genetic Variant Status: Insights from VALOR-HCM Trial.Milind Y Desai, Anjali Owens, Sara Saberi, Andrew Wang, Kathy Wolski
Circulation. Genomic and Precision Medicine. 2025-03-31 - Low Penetrance Sarcomere Variants Contribute to Additive Risk in Hypertrophic Cardiomyopathy.Joshua K Meisner, Aaron Renberg, Eric D Smith, Yao-Chang Tsan, Brynn Elder
Circulation. 2025-03-18
Journal Articles
- Exercise Hemodynamics in Hypertrophic Cardiomyopathy Identify Risk of Incident Heart Failure but Not Ventricular Arrhythmias or Sudden Cardiac Death☆Sharlene M Day, Sara Saberi, International Journal of Cardiology
Press Mentions
Cytokinetics Presents Positive Results from Cohort 4 of REDWOOD-HCM and Long-Term Results from FOREST-HCM at the American College of Cardiology 72nd Annual Scientific SessionMarch 4th, 2023- REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health StatusOctober 7th, 2022
- FDA Approves Camzyos for the Treatment of Obstructive Hypertrophic CardiomyopathyMay 6th, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
